Look at DAYBUE™ (Trofinetide) as first ever drug for treatment of Rett Syndrome [0.03%]
关注DAYBUE™(特罗尼替德)作为第一个用于治疗雷特综合征的药物
Muiz Khan Tareen,Zayed Mohiyuddin
Muiz Khan Tareen
Extremely Low Frequency, Extremely Low Magnetic Environment for depression: An open-label trial [0.03%]
极低频，极低磁场治疗抑郁症的开放性试验
Masako Tachibana,Toshiya Inada,Hiroki Kimura et al.
Masako Tachibana et al.
Mitochondrial dysfunction has been suggested to play a role in depression pathogenesis. This clinical trial (jRCTs042220011) was conducted to evaluate whether depression symptoms could be alleviated by an Extremely Low Frequency, Extremely ...
Clinical Trial
Asian journal of psychiatry. 2024 Jun:96:104036. DOI:10.1016/j.ajp.2024.104036 2024
Single arketamine in treatment resistant depression: Presentation of 3 cases with regard to sick-leave duration [0.03%]
氯胺酮在难治性抑郁症中的应用：基于病假时长的3例报道
Adam Włodarczyk,Jakub Słupski,Joanna Szarmach et al.
Adam Włodarczyk et al.
Background: Ketamine is the prototypal rapid-acting antidepressant (RAAD) for TRD with approved indication for esketamine-nasal spray (ESK-NS). Distinctly, arketamine (R-KET) demonstrates enhanced antidepressant effects a...
Corrigendum to Hypo- and hyper-activation in frontotemporal lobe during humor processing in patients with first episode schizophrenia" [Asian J. Psychiatry 92 (2024) 103892] [0.03%]
关于“首发精神分裂症患者在幽默加工过程中前额叶和颞叶低活和高活”一文的勘误 notice to "首发精神分裂症患者在幽默加工过程中前额叶和颞叶低活和高活" [Asian J. Psychiatry 92 (2024) 103892]
Bingjie Huang,Chengcheng Pu,Xiaodong Guo et al.
Bingjie Huang et al.
Published Erratum
Asian journal of psychiatry. 2024 Jun:96:104035. DOI:10.1016/j.ajp.2024.104035 2024
A real-world retrospective cohort study comparing two bilateral stimulation protocols of add-on rTMS in patients with treatment resistant depression and severe anxiety [0.03%]
一项在难治性抑郁伴重度焦虑患者中比较两种重复经颅磁刺激方案的回顾性队列研究
Michael Kabar,Luis Lopez-Chau,William J Araujo-Banchon
Michael Kabar
Background: Transcranial magnetic stimulation (TMS) has been shown to improve response and remission in patients with treatment resistant depression. The objective of this study was to compare the efficacy of two bilatera...
Comparative Study
Asian journal of psychiatry. 2024 Jun:96:104013. DOI:10.1016/j.ajp.2024.104013 2024
"Suicide among children and adolescents in India: Understanding the urgent need for action" [0.03%]
“印度儿童和青少年自杀问题：了解采取行动的紧迫性”
Thangaduraipandi Ramakrishnan,Alen Chandy Alexander,Anish V Cherian et al.
Thangaduraipandi Ramakrishnan et al.
Prevalence of catatonic symptoms and its relationship with coagulation profile and inflammatory markers among patients admitted in psychiatry ward [0.03%]
住院精神病患者的紧张症状流行率及其与凝血和炎症标志物的关系
Nikita Achar,Priti Arun,Seema Gupta et al.
Nikita Achar et al.
Beyond conventional: Feasibility of accelerated tACS in clozapine-resistant schizophrenia - A case report [0.03%]
超越常规：氯氮平抵抗性精神分裂症加速tACS可行性案例报告
Harsh Pathak,Kiran Bagali,Swarna Buddha Nayok et al.
Harsh Pathak et al.
Safety and efficacy of repetitive stimulation of the left dorsolateral prefrontal cortex using transcranial focused ultrasound in treatment-resistant depressed patients: A non-inferiority randomized controlled trial protocol [0.03%]
左背外侧前额叶重复经颅聚焦超声刺激治疗难治性抑郁患者的安全性和非劣效性随机对照试验方案
Gustavo Dos Santos Alves Maria,Natália Silva Dias,Rodrigo Nicolato et al.
Gustavo Dos Santos Alves Maria et al.
Background: About 30% of patients diagnosed with major depressive disorder fail with the mainstream pharmacological treatment. Patients who do not achieve clinical remission of symptoms, even with two different antidepres...
MicroRNA-124 influenced depressive symptoms via large-scale brain connectivity in major depressive disorder patients [0.03%]
microRNA-124通过影响大规模脑连接与抑郁症患者的抑郁症状有关
Cancan He,Qing Wang,Dandan Fan et al.
Cancan He et al.
This study aimed to investigate the neurobiological mechanisms by which microRNA 124 (miR-124) is involved in major depressive disorder (MDD). We enrolled 53 untreated MDD patients and 38 healthy control (HC) subjects who completed behavior...